Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 1, 2005, Pages 27-34

  Gan, Xiaohong Tracey ^a   Rajapurohitam, Venkatesh ^a   Haist, James V ^a   Chidiac, Peter ^a   Cook, Michael A ^a   Karmazyn, Morris ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLOROADENOSINE; 3 PROPYL 6 ETHYL [5 ETHYL(THIO)CARBONYL] 2 PHENYL 4 PROPYL 3 PYRIDINECARBOXYLATE; 6 ETHYL 4 PROPYL 2 PHENYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE DERIVATIVE; CAFFEINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHENYLEPHRINE; PROTEIN; RECEPTOR SUBTYPE; RGS2 PROTEIN; RGS4 PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; GENE INDUCTION; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ADENOSINE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; DRUG INTERACTIONS; HYPERTROPHY; MYOCYTES, CARDIAC; PHENETHYLAMINES; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A3;

EID: 11844254793     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.073122     Document Type: Article

References (29)

1. Alvarez BV, Ennis IL, De Hurtado MC, and Cingolani HE (2002) Effects of antihypertensive therapy on cardiac sodium/hydrogen ion exchanger activity and hypertrophy in spontaneously hypertensive rats. Can J Cardiol 18:667-672.
2. Auchampach JA, Ge ZD, Wan TC, Moore J, and Gross GJ (2003) A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol 285:H607-H613.
3. + exchanger. Br J Pharmacol 131:659-662.
4. Babu GJ, Lalli MJ, Sussman MA, Sadoshima J, and Periasamy M (2000) Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy. J Mol Cell Cardiol 32:1447-1457.
5. 2A adenosine receptors: dependent of phosphatidylinositol 3-kinase pathway. J Cardiovasc Pharmacol 43:416-422.
6. Bueno OF and Molkentin JD (2002) Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91:776-781.
7. + exchanger. Cardiovasc Res 53:862-868.
8. Chidiac P and Roy AA (2003) Activity, regulation and intracellular localization of RGS proteins. Receptors Channels 9:135-147.
9. Chung ES, Perlini S, Aurigemma GP, Fenton RA, Dobson JG Jr, and Meyer TE (1998) Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. J Hypertens 16:1813-1822.
10. + exchange hyperactivity and myocardial hypertrophy: are they linked phenomena? Cardiovasc Res 44:462-467.
11. Dubey RK, Gillespie DG, Zacharia LC, Mi Z, and Jackson EK (2001) A(2b) receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts. Hypertension 37:716-721.
12. Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, and Hori M (1997) Plasma adenosine levels increase in patients with chronic heart failure. Circulation 95:1363-1365.
13. Headrick JP, Hack B, and Ashton KJ (2003) Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol 285:H1797-H1818.
14. Henry P, Demolombe S, Puceat M, and Escande D (1996) Adenosine A1 stimulation activates delta-protein kinase C in rat ventricular myocytes. Circ Res 78:161-165.
15. ATP channel. J Pharmacol Exp Ther 294:770-777.
16. Karmazyn M (2001) Role of sodium-hydrogen exchange in cardiac hypertrophy and heart failure: a novel and promising therapeutic target. Basic Res Cardiol 96:325-328.
17. Karmazyn M and Cook MA (1992) Adenosine A1 receptor activation attenuates cardiac injury produced by hydrogen peroxide. Circ Res 71:1101-1110.
18. Karmazyn M, Liu Q, Gan XT, Brix BJ, and Fliegel L (2003) Aldosterone increases NHE-1 expression and induces NHE-1-dependent hypertrophy in neonatal rat ventricular myocytes. Hypertension 42:1171-1176.
19. Kitakaze M and Hori M (2000) Adenosine therapy: a new approach to chronic heart failure. Expert Opin Investig Drugs 9:2519-2535.
20. Kitakaze M, Minamino T, Node K, Koretsune Y, Komamura K, Funaya H, Kuzuya T, and Hori M (1998) Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure. Cardiovasc Drugs Ther 12:307-309.
21. Liao Y, Takashima S, Asano Y, Asakura M, Ogai A, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, et al. (2003) Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circ Res 93:759-766.
22. Ohnishi A, Li P, Branch RA, Biaggioni IO, and Jackson EK (1988) Adenosine in renin-dependent renovascular hypertension. Hypertension 12:152-161.
23. Rogers JH, Tamirisa P, Kovacs A, Weinheimer C, Courtois M, Blumer KJ, Kelly DP, and Muslin AJ (1999) RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J Clin Investig 104:567-576.
24. Schulte G and Fredholm BB (2003) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15:813-827.
25. Takeishi Y, Jalili T, Hoit BD, Kirkpatrick DL, Wagoner LE, Abraham WT, and Walsh RA (2000) Alterations in Ca2+ cycling proteins and G alpha q signaling after left ventricular assist device support in failing human hearts. Cardiovasc Res 45:883-888.
26. Yamada K, Goto A, Ishii M, Yoshioka M, Matsuoka H, and Sugimoto T (1992) Plasma adenosine concentrations are elevated in conscious spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 19:563-567.
27. 1 receptor-mediated cardioprotection in stunned canine myocardium. Circulation 88:235-244.
28. Zafeiridis A, Jeevanandam V, Houser SR, and Margulies KB (1998) Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98:656-662.
29. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, and Glembotski CC (1997) A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization and cardiac-specific gene expression. J Cell Biol 139:115-127.